Monoclonal Antibody, MORAb-009, Receives FDA Orphan Drug Designation For The Indication Of Pancreatic Cancer (Medical News Today)
Published by Yahoo! News Search Results for Food and Drug Admin November 8th, 2006 in Yahoo FDA News, Regulatory AffairsMorphotek(R) Inc., a privately held biopharmaceutical company focused on the discovery and development of therapeutic monoclonal antibodies, announces that the United States Food and Drug Administration (FDA) has granted orphan drug status to MORAb-009, a monoclonal antibody, for the indication of pancreatic cancer. [click link for full article]